TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia ; volume:24 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-7 ; date:12.2024
BMC pediatrics ; 24, Heft 1 (10.9.2024), 1-7, 12.2024
- Urheber
-
Qiu, Kun-yin
Liao, Xiong-yu
Fang, Jian-pei
Zhou, Dun-hua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-024-05053-x
- URN
-
urn:nbn:de:101:1-2411242101109.334847447722
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qiu, Kun-yin
- Liao, Xiong-yu
- Fang, Jian-pei
- Zhou, Dun-hua
- SpringerLink (Online service)
Ähnliche Objekte (12)
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia
Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia
Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia
Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study